{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:52:35Z","timestamp":1791384755041,"version":"4.3.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate real-world auxological and biochemical outcomes in children and adolescents with isolated growth hormone deficiency (GHD) who transitioned from daily recombinant human growth hormone to once-weekly somatrogon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Single-centre retrospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-three paediatric patients with isolated GHD (52 boys) transitioned to weekly somatrogon at a mean age of 12.56 \u00b1 2.87 years. At the time of data collection, all 73 patients had completed 6 months of follow-up, while 58 and 27 patients had completed 12 and 18 months, respectively. Primary outcomes were changes in height standard deviation score (SDS) and height velocity SDS. Secondary outcomes included body mass index (BMI) SDS, weight SDS, and serum insulin-like growth factor-1 (IGF-1) SDS. Assessments were performed 6 months prior to transition and at 6, 12, and 18 months after initiation of long-acting growth hormone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Height SDS increased, while height velocity SDS remained positive throughout follow-up. BMI SDS increased significantly during the first year after transition but stabilized by 18 months. Serum IGF-1 SDS showed an early increase at 6 months, followed by a decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Transition from daily growth hormone to once-weekly somatrogon maintained effective growth outcomes in paediatric patients with isolated GHD. These findings support the effectiveness of weekly therapy in routine clinical practice. Further long-term studies are needed to better characterize metabolic effects and inform individualized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag185","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:56:03Z","timestamp":1790164563000},"page":"590-599","source":"Crossref","is-referenced-by-count":0,"title":["Transition to once-weekly growth hormone in paediatric isolated growth hormone deficiency: a real-world experience"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4554-3116","authenticated-orcid":false,"given":"Georgia","family":"Sotiriou","sequence":"first","affiliation":[{"name":"1st Paediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Ippokratio General Hospital , Thessaloniki 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moutafi","sequence":"additional","affiliation":[{"name":"1st Paediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Ippokratio General Hospital , Thessaloniki 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Triantafyllou","sequence":"additional","affiliation":[{"name":"1st Paediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Ippokratio General Hospital , Thessaloniki 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papagianni","sequence":"additional","affiliation":[{"name":"1st Paediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Ippokratio General Hospital , Thessaloniki 54642 ,","place":["Greece"]},{"name":"Department of Nutrition and Dietetics, University of Thessaly , Trikala 42132 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[{"name":"1st Paediatric Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Ippokratio General Hospital , Thessaloniki 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"11","key":"2026100710020244500_lvag185-B1","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1210\/jcem.85.11.6984","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society. GH research society","volume":"85","author":"Growth Hormone Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026100710020244500_lvag185-B2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.beem.2016.11.004","article-title":"Metabolic alterations in paediatric GH deficiency","volume":"30","author":"Rothermel","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026100710020244500_lvag185-B3","doi-asserted-by":"publisher","first-page":"101392","DOI":"10.1016\/j.ghir.2021.101392","article-title":"Impact of short stature on quality of life: a systematic literature review","volume":"57\u201358","author":"Backeljauw","year":"2021","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"2026100710020244500_lvag185-B4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-16-1024","article-title":"Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet\u00ae international outcome study","volume":"177","author":"Polak","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026100710020244500_lvag185-B5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1210\/jc.2011-2294","article-title":"Long-term surveillance of growth hormone therapy","volume":"97","author":"Rosenfeld","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026100710020244500_lvag185-B6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.eprac.2022.02.013","article-title":"Association of daily growth hormone injection adherence and height among children with growth hormone deficiency","volume":"28","author":"Loftus","year":"2022","journal-title":"Endocr Pract"},{"key":"2026100710020244500_lvag185-B7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3389\/fendo.2018.00688","article-title":"Shared decision-making in growth hormone therapy\u2014implications for patient care","volume":"9","author":"Acerini","year":"2018","journal-title":"Front Endocrinol"},{"issue":"3","key":"2026100710020244500_lvag185-B8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s12020-025-04269-w","article-title":"Quality of life and treatment burden of children receiving daily growth hormone treatment in Greece","volume":"89","author":"Christoforidis","year":"2025","journal-title":"Endocrine"},{"key":"2026100710020244500_lvag185-B9","author":"Skytrofa"},{"key":"2026100710020244500_lvag185-B10","author":"Sogroya"},{"key":"2026100710020244500_lvag185-B11","author":"Ngenla"},{"issue":"2","key":"2026100710020244500_lvag185-B12","doi-asserted-by":"publisher","first-page":"bvaf001","DOI":"10.1210\/jendso\/bvaf001","article-title":"IGF-1 Assessment during weekly somatrogon treatment in pediatric patients with GH deficiency","volume":"9","author":"Nayak","year":"2025","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026100710020244500_lvag185-B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","article-title":"Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 national center for health statistics version","volume":"109","author":"Ogden","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"2026100710020244500_lvag185-B14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/00365513.2012.755739","article-title":"Reference values for serum levels of insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3) in the West Black Sea region of Turkey","volume":"73","author":"Guven","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"2026100710020244500_lvag185-B15","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1210\/jc.2013-4455","article-title":"Age-based reference ranges for annual height velocity in US children","volume":"99","author":"Kelly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026100710020244500_lvag185-B16","doi-asserted-by":"publisher","first-page":"e2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026100710020244500_lvag185-B17","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1210\/clinem\/dgac513","article-title":"Weekly somapacitan is effective and well tolerated in children with GH deficiency: the randomized phase 3 REAL4 trial","volume":"107","author":"Miller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026100710020244500_lvag185-B18","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment\u2013na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026100710020244500_lvag185-B19","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1038\/s41598-024-58616-4","article-title":"Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"2026100710020244500_lvag185-B20","doi-asserted-by":"publisher","first-page":"e82998","DOI":"10.7759\/cureus.82998","article-title":"Comparative efficacy of once-weekly somatrogon versus daily growth hormone therapy in children with idiopathic growth hormone deficiency: a real-world retrospective study from Greece","volume":"17","author":"Katsoudas","year":"2025","journal-title":"Cureus"},{"issue":"2","key":"2026100710020244500_lvag185-B21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4274\/jcrpe.galenos.2025.2025-6-24","article-title":"Real-world efficacy of weekly somatrogon on growth and bone health in pediatric growth hormone deficiency: a 12-month retrospective cohort study","volume":"18","author":"Awad","year":"2026","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"2026100710020244500_lvag185-B22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13023-025-03898-8","article-title":"First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry","volume":"20","author":"Woelfle","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"2026100710020244500_lvag185-B23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1530\/endoabs.110.EP759","article-title":"Real world data for the first year of treatment with somatrogon of children and adolescents with growth hormone deficiency (GHD)","volume":"110","author":"Dikaiakou","year":"2025","journal-title":"Endocr Abstr"},{"key":"2026100710020244500_lvag185-B24","doi-asserted-by":"publisher","first-page":"1685851","DOI":"10.3389\/fendo.2026.1685851","article-title":"Two-year real-world experience with somatrogon in children and adolescents with growth hormone deficiency","volume":"17","author":"Tamaro","year":"2026","journal-title":"Front Endocrinol"},{"key":"2026100710020244500_lvag185-B25","doi-asserted-by":"publisher","first-page":"101705","DOI":"10.1016\/j.ghir.2026.101705","article-title":"Is somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from somatropin to somatrogon","volume":"84","author":"Atas","year":"2026","journal-title":"Growth Horm IGF Res"},{"issue":"2):","key":"2026100710020244500_lvag185-B26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4274\/jcrpe.galenos.2026.2025-11-4","article-title":"Once-weekly somatrogon in pediatric growth hormone deficiency: real-world efficacy, safety, and quality-of-life findings","volume":"18","author":"K\u00fc\u00e7\u00fck","year":"2026","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"2026100710020244500_lvag185-B27","doi-asserted-by":"publisher","first-page":"e1232","DOI":"10.1210\/clinem\/dgae834","article-title":"Long-acting growth hormone therapy in pediatric growth hormone deficiency: a consensus statement","volume":"110","author":"Maniatis","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026100710020244500_lvag185-B28","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1210\/jc.2019-00775","article-title":"Treatment of children with GH in the United States and Europe: long-term follow-up from NordiNet\u00ae IOS and ANSWER program","volume":"104","author":"S\u00e4vendahl","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026100710020244500_lvag185-B29","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00431-022-04409-8","article-title":"Safety and effectiveness of omnitrope\u00ae (somatropin) in PATRO children: a multi-center, post-marketing surveillance study comparison of US and international cohort data","volume":"181","author":"Backeljauw","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"7","key":"2026100710020244500_lvag185-B30","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1210\/jc.2008-0079","article-title":"Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting","volume":"93","author":"Sakharova","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100710020244500_lvag185-B31","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.mce.2020.111038","article-title":"Effect of growth hormone on insulin signaling","volume":"518","author":"Sharma","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2026100710020244500_lvag185-B32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/cells10010129","article-title":"Central regulation of metabolism by growth hormone","volume":"10","author":"Donato","year":"2021","journal-title":"Cells"},{"key":"2026100710020244500_lvag185-B33","doi-asserted-by":"publisher","first-page":"101714","DOI":"10.1016\/j.ghir.2026.101714","article-title":"Real world performance of once weekly somatrogon on naive patients with isolated growth hormone deficiency: mind the weight gain","volume":"85","author":"Moutafi","year":"2026","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"2026100710020244500_lvag185-B34","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1210\/clinem\/dgag093","article-title":"Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index","volume":"111","author":"Levaillant","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026100710020244500_lvag185-B35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.eprac.2025.03.005","article-title":"Efficacy of somapacitan in treatment-fatigue adult patients with growth hormone deficiency previously treated with once-daily growth hormone injections: a 24-week randomized active-controlled trial","volume":"31","author":"Jensterle","year":"2025","journal-title":"Endocr Pract"},{"issue":"38","key":"2026100710020244500_lvag185-B36","doi-asserted-by":"publisher","first-page":"e34730","DOI":"10.1097\/MD.0000000000034730","article-title":"Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: a real-world pilot study","volume":"102","author":"Abe","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2026100710020244500_lvag185-B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.23750\/abm.v91i1.9182","article-title":"Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and turner syndrome (TS) in a tertiary care center","volume":"91","author":"Shaikh","year":"2020","journal-title":"Acta Biomed"},{"issue":"1","key":"2026100710020244500_lvag185-B38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.6065\/apem.2142110.055","article-title":"Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency","volume":"27","author":"Yoon","year":"2022","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2026100710020244500_lvag185-B39","doi-asserted-by":"publisher","first-page":"1288497","DOI":"10.3389\/fendo.2024.1288497","article-title":"Clinical and laboratory characteristics but not response to treatment can distinguish children with definite growth hormone deficiency from short stature unresponsive to stimulation tests","volume":"15","author":"Lanzetta","year":"2024","journal-title":"Front Endocrinol"},{"issue":"5-6","key":"2026100710020244500_lvag185-B40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000518995","article-title":"The boy:girl ratio of children diagnosed with growth hormone deficiency-induced short stature is associated with the boy:girl ratio of children visiting short stature clinics","volume":"94","author":"Tanaka","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"9-10","key":"2026100710020244500_lvag185-B41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000520250","article-title":"Growth hormone stimulation testing patterns contribute to sex differences in pediatric growth hormone treatment","volume":"94","author":"Kamoun","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"1-2","key":"2026100710020244500_lvag185-B42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/jpem-2014-0003","article-title":"Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?","volume":"28","author":"Ben-Ari","year":"2015","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"1","key":"2026100710020244500_lvag185-B43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/children12010058","article-title":"Severe lipoatrophy in a growth hormone deficient toddler girl treated with a non-pegylated long-acting growth hormone","volume":"12","author":"B\u00fcy\u00fckgebiz","year":"2025","journal-title":"Children"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag185\/71375366\/lvag185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/590\/71375366\/lvag185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/590\/71375366\/lvag185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:02:11Z","timestamp":1791381731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/4\/590\/8833443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag185","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,24]]}}}